Search Results
162 results
Your search is now limited to «FDA Actions» expert search.
GlobeNewswire 04/18/2019 08:05
The FDA deferred selection of the primary efficacy endpoint to Corbus.
More from GlobeNewswire:
Healio News 04/16/2019 13:41
FDA approves new HIV regimen, reliance on pre-exposure prophylaxis may increase risk for STIs.
More from Healio News:
Becker's Hospital Review 04/12/2019 11:38
The FDA expanded indication of Ibrance, a metastatic breast cancer treatment, to include male patients.
More from Becker's Hospital Review:
The FDA maintains there is not enough evidence to link breast implants and connective tissue diseases like lupus and rheumatoid arthritis.
More from National Center For Health Research:
FDLI SmartBrief 04/11/2019 09:44
Viiv Healthcare's Dovato, or dolutegravir and lamivudine, has been approved by the FDA for use in adult patients with HIV-1 infection who have never received antiretroviral therapy and have no known resistance to either lamivudine or dolutegravir.
More from FDLI SmartBrief:
Zacks.com 04/10/2019 09:20
While Amgen ( AMGN - Free Report) received an FDA nod for its osteoporosis drug, Gilead Sciences, Inc. ( GILD - Free Report) has submitted an application for the label expansion of its HIV drug, Descovy.
More from Zacks.com:
FDA has approved dolutegravir and lamivudine as a complete regimen for treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of the drug ...

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications